2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | 24.740 | 23.085 | 28.610 | 28.431 | 23.895 | 27.277 | 30.426 |
Total Income - EUR | - | - | - | 24.740 | 23.085 | 28.726 | 31.015 | 23.895 | 27.277 | 30.426 |
Total Expenses - EUR | - | - | - | 10.011 | 10.288 | 12.112 | 9.504 | 11.105 | 9.930 | 5.844 |
Gross Profit/Loss - EUR | - | - | - | 14.729 | 12.797 | 16.614 | 21.511 | 12.790 | 17.347 | 24.582 |
Net Profit/Loss - EUR | - | - | - | 13.987 | 12.104 | 15.756 | 20.610 | 12.073 | 16.545 | 20.556 |
Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oftalmo-Bioptics Med Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | 6.406 | 5.776 | 4.374 | 230 | 0 | 0 | 0 |
Current Assets | - | - | - | 7.959 | 7.056 | 12.043 | 20.870 | 12.330 | 17.208 | 21.734 |
Inventories | - | - | - | 0 | 1.047 | 0 | 0 | 0 | 0 | 0 |
Receivables | - | - | - | 0 | 0 | 330 | 71 | 2 | 2 | 22 |
Cash | - | - | - | 7.959 | 6.009 | 11.714 | 20.799 | 12.328 | 17.206 | 21.712 |
Shareholders Funds | - | - | - | 14.031 | 12.156 | 15.806 | 20.660 | 12.122 | 16.594 | 20.605 |
Social Capital | - | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | 334 | 677 | 611 | 440 | 209 | 615 | 1.129 |
Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8622
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Oftalmo-Bioptics Med Srl